期刊文献+

2型糖尿病与脂肪肝、胆囊炎、胆结石和脂代谢的相关因素分析 被引量:6

The analysis on relative factors of type 2 diabetes mellitus and fatty liver, cholecystitis, cholelithiasis and lipid metabolism
暂未订购
导出
摘要 目的:探讨糖尿病与脂肪肝、胆囊炎、胆结石和脂代谢的关系。方法:2型糖尿病(T2DM)住院患者112例,行上腹部B超检查,将其伴脂肪肝、胆囊炎、胆结石情况与脂代谢异常、T2DM病程、年龄等临床相关因素进行分析,抽样同期住院的39例非DM患者作为对照进行对比。结果:T2DM患者上腹部B超检查阳性率明显高于非DM组,T2DM患者中B超阳性组的血脂异常水平明显高于B超阴性组,亦明显高于非DM组。T2DM伴脂肪肝和(或)胆囊炎、胆结石与TC、TG、LDL-C和ApoB呈正相关,与HDL-C无显著相关性,与ApoA1、年龄和病程呈负相关。结论:T2DM患者伴脂肪肝、胆囊炎和胆结石的发病率明显高于非DM患者,其发生与脂代谢异常关系密切。 Objective: To investigate the relationship between type 2 diabetes mellitus (T2DM)and fatty liver, cholecystitis, cholelithiasis and lipid metabolism.Methods: To collect 112 patients with type 2 diabetes mellitus who had received B-ultrasonic examination on upper belly,and analyze relative factors such age, course of disease, complication (fatty liver, cholecystitis, cholelithiasis) and lipid metabolic disorder, then contrast in parallel with 39 non-diabetes patients as control at the same time. Results:B-uhrasonic examination positive rate in diabetic patients was much higher than in negative ones. Lipid metabolic disorder in diabetes in B-ultrasonic positive group was higher than that in negative group and much higher than non-diabetic individuals.Patients with type 2 diabetes with fatty liver, cholecystitis and cholelithiasis were positive correlated to TC, TG, LDL-C and ApoB, They were negative correlated to age, course of T2DM and ApoA1, And there were none clear-cut correlation between the patients and HDL-C, Conclusion: Patients with type 2 diabetes appear more easily suffered from fatty liver, cholecystitis and cholelithiasis than inpatients with non-diabetes, which counted for partly lipid metabolic disorder.
出处 《中国医药导报》 CAS 2008年第3期11-13,共3页 China Medical Herald
关键词 2型糖尿病 脂肪肝 胆结石 脂代谢异常 代谢紊乱 Diebetes mellitus Fatty liver Cholelithiasis Lipid metabolic disorder
  • 相关文献

参考文献5

二级参考文献12

  • 1陈灏珠.实用内科学(第10版)[M].北京:人民卫生出版社,1998.1765-1767.
  • 2涂春华.高血脂和胆囊收缩功能关系的探讨[J].中国超声医学杂志,1992,8(4):279-279.
  • 3[1]Haffner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the HOMA model. The Mecico city diabetes study. Diabetes Care,1996, 19:1138-1141.
  • 4[2]Kumar KS, Malet PF. Nonalcoholic steatohepatitis. Mayo-Clin-Proc,2000, 75:733-739.
  • 5[3]Luyckx FH, Lefebvre PJ, Scheen AJ. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab, 2000, 26 : 98-106.
  • 6[5]Cortez-Pinto-H, Camilo ME, Baptista A, et al. Non-alcoholic fatty liver:another feature of the metabolic syndrome? Clin-Nutr, 1999, 18: 353-358.
  • 7[6]Herranz L, Zapata A, Grande C, et al. Body fat distribution, insulin mediated suppression of non-esterified fatty acids and plasma triglycerides in obese subjects. Horm Metab Res. 1998, 30:141-145.
  • 8[7]Van-Steenbergen W, Lanckmans S. Liver disturbances in obesity and diabetes mellitus. Int-J-Obes-Relat-Metab-Disord. 1995, 19(Suppl 3):S27-36.
  • 9[8]Pares A, Tresserras R, Nunez I, et al. Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men. Med-ClinBarc. 2000,114:561-565.
  • 10武建军,苏内林,秦二平,高翔云,陈继先,武秀英.糖尿病人胆囊收缩功能观察[J].临床肝胆病杂志,1998,14(4):244-244. 被引量:3

共引文献1404

同被引文献34

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部